In many neurodegenerative disorders, aggregates of ubiquitinated proteins are detected in neuronal inclusions, but their role in neurodegeneration remains to be defined. To identify intracellular mechanisms associated with the appearance of ubiquitin-protein aggregates, mouse neuronal HT4 cells were treated with cadmium. This heavy metal is a potent cell poison that mediates oxidative stress and disrupts the ubiquitin/ proteasome pathway. In the current studies, the following intracellular events were found to be also induced by cadmium: (i) a specific rise in cyclooxygenase-2 (COX-2) gene expression but not COX-1; (ii) an increase in the extracellular levels of the proinflammatory prostaglandin E2, a product of COX-2; and (iii) production of 4-hydroxy-2-nonenal-protein adducts, which result from lipid peroxidation. In addition, cadmium treatment led to the accumulation of high molecular weight ubiquitin-COX-2 conjugates and perturbed COX-2 glycosylation. The thiol-reducing antioxidant N-acetylcysteine, and, to a lesser extent, the COX-2 inhibitor celecoxib, attenuated the loss of cell viability induced by cadmium demonstrating that oxidative stress and COX-2 activation contribute to cadmium cytotoxicity. These findings establish that disruption of the ubiquitin/proteasome pathway is not the only event triggered by cadmium. This oxidative stressor also activates COX-2 function. Both events could be triggered by formation of 4-hydroxy-2-nonenal as a result of cadmium-induced lipid peroxidation. Proinflammatory responses stimulated by oxidative stressors that mimic the cadmium effects may, therefore, be important initiators of the neurodegenerative process and exacerbate its progress.
The ubiquitin/proteasome pathway plays a major role in the intracellular quality control process by degrading mutated or abnormally folded proteins to prevent their accumulation as aggregates (for review, see Ref. 1). In many neurodegenerative disorders, however, aggregates of ubiquitinated proteins are detected in neuronal inclusions (for review, see Ref. 2) . A correlation between neuronal inclusions and cell death remains to be established (3, 4) . Nevertheless, recent findings demonstrated that protein aggregates directly impair the function of the ubiquitin/proteasome pathway, known to be essential for cell survival (5) .
It has become increasingly evident that functional changes in the ubiquitin/proteasome pathway are critical to the neurodegenerative process. For example, a mutant form of ubiquitin (Ub), 1 known as Ub ϩ1 , was detected only in brains of Alzheimer's disease (AD) patients and not in age-matched controls (6) . Ub ϩ1 -capped polyubiquitin chains were shown to be refractory to disassembly by de-ubiquitinating enzymes and to inhibit proteasome degradation of a polyubiquitinated substrate potently (7) . Moreover, particular areas of AD brains were found to exhibit compromised proteasome activities compared with age-matched controls (8) . In addition, a decline in ubiquitination activity was shown to decrease cell viability in a cellular model of Huntington's disease (9) . In this model, transfected rat striatal neurons coexpressing a nonfunctional ubiquitin-conjugating enzyme and a mutant huntingtin containing polyglutamine expansions showed a greater loss of cell viability than transfectants expressing the huntingtin mutant alone (9) . Together, these results strongly support the view that disruption of the ubiquitin/proteasome pathway plays an important role in neurodegeneration.
Oxidative stress is another mechanism found to be involved in neurodegeneration. Increasing evidence supports its role in neuronal death in disorders such as AD and Parkinson's disease. Studies with autopsied brains of AD patients show a colocalization of high levels of oxidative stress products with neurofibrillary tangles and senile plaques (10) . Furthermore, signs of oxidative stress, such as lipid peroxidation and a decline in reduced glutathione (GSH), were detected in the substantia nigra in brains of Parkinson's disease patients (11) . The production of free radicals by oxidative stress promotes partial unfolding of cellular proteins, resulting in exposure of previously buried hydrophobic domains to proteolytic enzymes (12) (13) (14) and to ubiquitin-conjugating enzymes (15) . This sudden increase in protein substrates may compromise the capacity of the ubiquitin/proteasome pathway to clear the abnormal proteins and cause their aggregation and accumulation within the cell. However, the link between oxidative stress and the accumulation of ubiquitinated proteins in neurodegeneration remains to be established.
To address the relationship between oxidative stress and disruption of the ubiquitin/proteasome pathway in the neurodegenerative process, we chose to treat mouse neuronal HT4 cells with cadmium (Cd 2ϩ ). This heavy metal increases lipid peroxidation in organs such as the brain, which is particularly sensitive to Cd 2ϩ toxicity (16) . Although Cd 2ϩ is not a Fenton metal and thus, by itself, is unable to generate reactive oxygen species (ROS), free radical scavengers and antioxidants lessen Cd 2ϩ toxicity, suggesting that the heavy metal elicits an increase in free radical production (for review, see Ref. 17) . Earlier studies (18) suggested a close link between Cd 2ϩ cytotoxicity and the ubiquitin/proteasome pathway because yeast mutants deficient in a specific ubiquitin-conjugating enzyme (UBC7) or a proteasome subunit (PRE1) were shown to be hypersensitive to the heavy metal. Moreover, our previous studies with neuronal cells (19, 20) demonstrated that Cd 2ϩ disrupts intracellular sulfhydryl homeostasis, leading to an accumulation of ubiquitinated proteins and to a loss in cell viability. The ubiquitinated proteins that accumulate in cells upon Cd 2ϩ treatment and the mechanisms mediating its toxicity in neuronal cells remain poorly defined.
Herein we report that, in mouse neuronal HT4 cells, Cd 2ϩ initiated a proinflammatory response by inducing up-regulation of COX-2 at the mRNA and protein levels without affecting COX-1. As a result of this response, there was an increase in the extracellular concentrations of the proinflammatory prostaglandin PGE2, which is a COX-2 product. Moreover, treatments with the heavy metal resulted in the stabilization of glycosylated and unglycosylated forms of COX-2 as well as an accumulation of ubiquitin-COX-2 conjugates. Cd 2ϩ also induced the formation of 4-hydroxy-2-nonenal (HNE)-protein adducts in the neuronal cells, indicating that its cytotoxicity may be mediated by HNE, a highly cytotoxic aldehyde product of lipid peroxidation. Based on the observations that Cd 2ϩ -induced oxidative stress is closely associated with COX-2 upregulation and neuronal cell death, we evaluated the protective effect of two antioxidants (N-acetylcysteine (NAC) and ascorbic acid) and a COX-2-specific inhibitor (celecoxib) on Cd 2ϩ cytotoxicity. Of the three drugs tested, NAC, a thiol-reducing antioxidant, was the most effective in preventing the loss of cell viability caused by the heavy metal. Ascorbic acid, a free radical scavenger, failed to prevent and even potentiated Cd 2ϩ cytotoxicity in some instances. Celecoxib, the COX-2-specific inhibitor, attenuated the loss of cell viability caused by the heavy metal under certain conditions. These studies provide evidence that both the disruption of the ubiquitin/proteasome pathway and the induction of a proinflammatory response are induced by oxidative stressors such as cadmium. These two mechanisms may be associated in the neurodegenerative process.
EXPERIMENTAL PROCEDURES
Materials-Cadmium sulfate, NAC, ascorbic acid, actinomycin D, puromycin, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide were from Sigma. Tunicamycin was from Calbiochem. Celecoxib was a generous gift from Pharmacia Corp. (Peapack, NJ). The goat polyclonal antibodies anti-COX-2 (1:1,000) and anti-COX-1 (1: 1,000) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Ubiquitin-protein conjugates were detected with a rabbit polyclonal antibody (1:1,500) from Dako Corp. (Carpinteria, CA). HNE-protein adducts were identified with a rabbit polyclonal antibody (1:1,000) from Calbiochem. The Super Signal West Pico detection system and the bicinchoninic acid protein assay kit were from Pierce Chemical Co. Other reagents were of the highest purity available.
Cell Cultures-HT4 cells were derived from a mouse neuroblastoma cell line infected with a retrovirus encoding the temperature-sensitive mutant of SV40 large T antigen. When grown at 39°C (nonpermissive temperature), HT4 cells differentiate with neuronal morphology, express neuronal antigens, synthesize and secrete nerve growth factor, and express receptors for nerve growth factor (21) . The cells were maintained at 33°C in Dulbecco's modified Eagle's medium containing 5% fetal bovine serum, as described previously (19) .
Cell Treatments-Cultures of HT4 cells were treated at 37°C with aqueous solutions of cadmium sulfate added to serum-containing medium. When specified, antioxidants (1 mM NAC or 1 mM ascorbic acid) or the COX-2 inhibitor celecoxib (20 M) or inhibitors of transcription (15 g/ml actinomycin D) or translation (25 g/ml puromycin) or an inhibitor of N-linked glycosylation (10 g/ml tunicamycin), was added to the culture medium 1 h before Cd 2ϩ treatment. NAC, ascorbic acid, and puromycin were dissolved in water, and the remaining listed drugs were dissolved in dimethyl sulfoxide. At the end of the indicated incubation times, the cultures were washed twice with phosphate-buffered saline, and the cells were harvested as described previously (22) . Cell washes removed unattached cells; hence, subsequent assays were performed on adherent cells only.
Preparation of Cell Extracts for Western Blotting-Cell extracts were prepared and subjected to SDS-PAGE as described previously (19) . Identification of COX-1, COX-2, ubiquitinated proteins, and HNE-protein adducts was by Western blotting on 8% polyacrylamide gels. For detection of HNE-protein adducts the samples were run under nonreducing conditions in the absence of ␤-mercaptoethanol. The antigens were visualized by a horseradish peroxidase method utilizing the Super Signal West Pico detection system. Quantitative analysis of the immunostaining was by image analysis with the ImagePC program from NIH as described previously (23) .
Reverse Transcription-PCR Analysis-Total RNA was isolated with the RNAeasy Kit from Qiagen (Valencia, CA). To perform each reverse transcription-PCR, 1 g of RNA/sample was reverse transcribed in a 25-l reaction (Omniscript reverse transcription kit from Qiagen), and 2 l of the resultant cDNA was amplified with gene-specific primers using the TaqPCR core kit from Qiagen. The mouse-specific PCR primers for cox-2 were CAGCACTTCACCCATCAGTT (forward) and CTG-GTCAATGGAGGCCTTTG (reverse), and for ubA they were CAACATC-CAGAAAGAGTCCA (forward) and CCTCATCTTGTCACAGTTGT (reverse). Primers were designed from cDNA sequences obtained from GenBank under the accession numbers M88242 for mouse cox-2 and M11690 for mouse ubA. PCR was performed for 5 min at 94°C, then 35 cycles for ubA and 30 cycles for cox-2 of 1 min at 94°C, 1 min at 60°C, and 1.5 min at 72°C with a final extension at 72°C for 10 min.
PGE2 Concentrations-Levels of PGE2 released into the medium of treated cells were measured by an enzyme-linked immunosorbent assay according to the manufacturer's instructions (Cayman Chemicals, Ann Arbor, MI). For all experiments, cells were seeded at a density of 1.5 ϫ 10 5 cells/ml. Amounts of PGE2 are expressed as ng of PGE2 produced/ml of medium.
Immunoprecipitation-Immunoprecipitation of COX-2 from total cell extracts, normalized to protein concentration, was performed as described previously (24) . The immunocomplexes were resolved on 8% SDS gels followed by Western blot analysis probed with the anti-COX-2 antibody and stripping and reprobing with the anti-ubiquitin conjugate antibody.
Cell Viability Assay-Cell viability was assessed with a modification of the method described by Mosmann (25) by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay as described previously (19) .
Glutathione Assay-Total GSH was quantified as described previously (26) by a modification of the standard recycling assay based on the reduction of 5,5-dithiobis(2-nitrobenzoic acid) with glutathione reductase and NADPH. This assay measures both GSH and GSSG; normally GSSG measures less than 5% of the total GSH in control cell cultures.
Protein Determination-Protein levels were determined with a bicinchoninic acid assay kit.
Statistical Analysis-Statistical comparisons between two groups (see Fig. 6 ) or among three or more groups (see Fig. 8 ) were performed with the unpaired t test or with the Tukey-Kramer multiple comparison test (Instat 2.0, GraphPad Software, San Diego), respectively.
RESULTS

Cadmium Induces a Time-and Dose-dependent Increase in COX-2 Protein Levels-To determine the time and concentration dependence of the effect of Cd
2ϩ on the intracellular levels of COX-2, we treated confluent HT4 cells with a range of concentrations between 1.5 and 45 M CdSO 4 . After incubations of 10 -48 h, intracellular levels of COX-2 in total lysates prepared from adherent cells were visualized by Western blot analysis as described under "Experimental Procedures." Fig. 1 shows the dose-dependent course of the changes in COX-2 levels after treatment for 10, 16, 24, and 48 h with CdSO 4 . Anti-COX-2 immunoreactivity detected a light 72 kDa band in control cells or cells treated with 1.5 M CdSO 4 . This band corresponds to COX-2 that is N-glycosylated at three sites (27) . In cells treated with higher Cd 2ϩ concentrations, such as 3, 15, 30 and, in some cases, 45 M, two additional bands were identified as corresponding to COX-2 forms that are N-glycosylated at four sites (74 kDa) and nonglycosylated (65 kDa), respectively (27) . The three COX-2 bands, corresponding to 74, 72, as well as 65 kDa, are clearly visible in Fig. 5 (see below). COX-2 levels rose above control as early as 10 h after treatment with 15 M CdSO 4 , which is the Cd 2ϩ concentration that most effectively increases COX-2 levels to a range between 3-and 38-fold above control (Fig. 1E) . In addition, a form of COX-2 (Ub-COX-2) which migrated at a high molecular weight was clearly identified at the top of blots corresponding to cells treated for 24 and 48 h with 15 M Cd 2ϩ (Fig. 1, C and D) . At higher Cd 2ϩ concentrations (45 M) the levels of all COX-2 forms decrease. This effect is most likely the result of a dramatic loss in cell viability caused by high Cd 2ϩ concentrations (see below).
Cadmium Up-regulates COX-2 Gene Expression-The increase in COX-2 protein levels observed in HT4 cells upon treatment with the heavy metal could result from either a reduction in COX-2 degradation or an increase in its expression. To establish whether cadmium affects cox-2 gene expression we carried out reverse transcription-PCR analyses with gene-specific primers. These studies revealed that CdSO 4 concentrations ranging between 3 and 30 M caused a considerable induction of cox-2 mRNA (Fig. 2A) . The ubA mRNA levels did not change significantly with these treatments. The levels of cox-2 and ubA mRNA were both decreased by 45 M CdSO 4 , most likely because of the high level of cell death elicited by this concentration of the heavy metal.
Pretreatment of HT4 cells with inhibitors of transcription (actinomycin D) or translation (puromycin) prevented the Cd 2ϩ -induced rise in COX-2 protein levels (compare Fig. 2B , top panel, with Fig. 2C ). Only the preexisting 72-kDa form of COX-2 was identified in cells pretreated with actinomycin D or puromycin. This finding demonstrates that the other COX-2 forms detected in cells treated solely with Cd 2ϩ , namely the 74-and 65-kDa forms as well as ubiquitinated-COX-2, are dependent on de novo protein synthesis.
The increase in cyclooxygenase levels induced by Cd 2ϩ is specific for COX-2. Protein levels of COX-1, which is constitutive in HT4 cells, were not raised by treatment with increasing concentrations of the heavy metal (Fig. 2B, lower panel) .
Cadmium Increases PGE2 Levels-To evaluate the functional changes in COX-2 levels shown in Fig. 1 , culture medium from HT4 cells incubated with different Cd 2ϩ concentrations over time were analyzed for production of the proinflammatory prostaglandin PGE2, a COX-2 product (Fig. 3) . In the absence of cadmium, HT4 cells maintained a basal level of ϳ0.25 ng of PGE2/ml of medium. After 24-h incubations with increasing concentrations of cadmium, PGE2 levels were elevated to a maximum of 90 ng of PGE2/ml of medium, a 360-fold increase over basal levels. After 48 h of treatment, PGE2 production in cells treated with 30 and 45 M Cd 2ϩ was at least 3-fold lower than in those treated with 15 M heavy metal. This decline in PGE2 production most likely reflects the poor cell survival caused by higher Cd 2ϩ concentrations.
Cadmium Induces Accumulation of High Molecular Mass Ubiquitin-COX-2 Conjugates and Perturbs COX-2 Glycosylation-
The COX-2 immunoreactive high molecular mass forms detected by Western blot analysis of total cell lysates probed with anti-COX-2 were characterized further for the presence of ubiquitin. Total lysates prepared from control and Cd 2ϩ -treated HT4 cells were subjected to imunoprecipitation with the anti-COX-2 antibody. Western blots of the immunoprecipitated proteins probed with the anti-COX-2 antibody (Fig. 4B ) revealed three COX-2 forms (74/72-kDa doublet and 65 kDa) as well as high molecular mass COX-2 (Ub-COX-2), a pattern of reactivity similar to the one observed in Fig. 1 . Only the high molecular mass COX-2 forms were detected when these blots were stripped and reprobed with the antibody that recognizes ubiquitin conjugates (Fig. 4A) . These findings suggest that Cd 2ϩ promotes stabilization of COX-2 as high molecular mass ubiquitin conjugates.
Treatment with endoglycosidase H reduced the apparent molecular mass of most of the 72/74-kDa doublet to the 65 kDa band (data not shown). The latter was also the major band identified in Cd 2ϩ -treated cells preincubated for 1 h with 10 g/ml tunicamycin, a glycosylation inhibitor (Fig. 5B) . The 65 kDa band corresponds, therefore, to unglycosylated COX-2. These results indicate that the shift in COX-2 apparent molecular masses seen in Cd 2ϩ -treated cells is the result of changes in the extent of its glycosylation and not its proteolytic degradation.
Evaluation of the Effect of Antioxidants and a COX-2 Inhibitor on Cadmium Cytotoxicity-To investigate which mechanisms mediate Cd
2ϩ cytotoxicity we evaluated the effects of two antioxidants, NAC and ascorbic acid, and a COX-2 inhibitor, celecoxib, on HT4 cell viability. The results obtained after treatments with 15, 30, and 45 M heavy metal for 7 or 24 h are shown in Fig. 6, A and B , respectively. The lowest survival rate was observed as an approximate 90% decrease in cell viability after a 24-h treatment with 45 M Cd 2ϩ . A 7-h treatment with the same Cd 2ϩ concentration caused a 45% reduction in cell viability.
The thiol-reducing agent NAC significantly (p Ͻ 0.05) attenuated the loss in cell viability caused by 7-h (Fig. 6Aa) or 24-h (Fig. 6Ba ) treatment with the three Cd 2ϩ concentrations tested. Moreover, celecoxib, a COX-2-specific inhibitor, significantly (p Ͻ 0.05) lessened the cytotoxic effect of 7-h incubations with the same three Cd 2ϩ concentrations (Fig. 6Ab) . The COX-2 inhibitor was less effective after 24-h incubations with the heavy metal by only significantly (p Ͻ 0.05) preventing the loss of viability of cells treated with 15 M Cd 2ϩ (Fig. 6Bb ). These findings suggest that the induction of a proinflammatory response is one of the early mechanisms activated by Cd 2ϩ and plays an important role in its cytotoxicity. However, in longer exposures to the heavy metal, other cytotoxic mechanisms may be activated sufficiently to override the effect of the proinflammatory response alone. COX-2 activity may then contribute to the acceleration of the cytotoxic process.
Remarkably, ascorbic acid failed to prevent the loss of cell viability caused by Cd 2ϩ treatment. In some instances, this free radical scavenger even intensified Cd 2ϩ cytotoxicity (Fig. 6Bc) . As discussed below, this effect could be the result of a synergism between the antioxidant and cadmium in causing lipid peroxidation (see "Discussion").
Inhibitors of transcription (actinomycin D) or translation (puromycin) did not significantly alter the loss of cell viability caused by 24-h treatments with Cd 2ϩ (Fig. 6B, d and e, respectively). These results suggest that under these conditions, de   FIG. 3 . Cadmium enhances production of the proinflammatory prostaglandin, PGE2. The levels of PGE2 produced by HT4 cells were assessed by enzyme-linked immunosorbent assay as described under "Experimental Procedures." Untreated HT4 cells produce ϳ0.25 ng of PGE2/ml of medium. Each curve represents changes in PGE2 levels after incubation with increasing Cd 2ϩ concentrations for 10 (E), 16 (q), 24 (Ⅺ), and 48 h (f). Data represent mean ng of PGE2 produced/ml of medium from two determinations within a representative experiment. novo protein synthesis of COX-2 is not the sole contributor to the cytotoxic process.
It should be noted that some of the drugs tested in these experiments, namely celecoxib, actinomycin D, and puromycin, were slightly cytotoxic. Their effect on Cd 2ϩ -mediated loss in cell viability, therefore, reflects a comparison with cells treated with the drugs alone.
Cadmium Induces the Production of HNE-Protein Adducts in HT4 Neuronal Cells-One of the effects of Cd
2ϩ -induced oxidative stress is lipid peroxidation. Because HNE is a product of lipid peroxidation, we investigated whether the heavy metal causes the formation of this highly cytotoxic aldehyde. Fig. 7 shows that 15, 30, and 45 M Cd 2ϩ induce the formation of HNE-protein adducts. These protein conjugates, with molecular masses above 132 kDa, are indicated at the top of the Western blot shown in Fig. 7 . Because HNE is known to be an extremely reactive electrophile, it is possible that the cytotoxic effect of Cd 2ϩ is potentiated by this aldehyde. The Cd 2ϩ -induced HNE-protein adducts were not detected in HT4 cells pretreated with NAC (Fig. 7, right lanes) . The latter is a sulfur-containing antioxidant, which reacts directly with free radicals and may therefore prevent lipid peroxidation.
NAC, but Not Ascorbic Acid, Prevents the Cadmium-induced Rise in COX-2 Levels as Well as the Decline in GSH Levels and
Attenuates PGE2 Production-To test further the hypothesis that oxidation of protein thiols and ROS production are events that mediate Cd 2ϩ toxicity we attempted to block some of the heavy metal effects with the thiol-reducing agent NAC. As seen in Fig. 8, 1 mM NAC prevented the Cd 2ϩ -induced increase in COX-2 protein levels (Fig. 8A, middle panel) and decline in GSH (Fig. 8B) , the latter measured after a 24-h treatment with 45 M Cd 2ϩ . In addition, NAC attenuated the Cd 2ϩ -induced rise in PGE2 levels detected in HT4 cells incubated with the heavy metal for 7 h (Fig. 8C ). Ascorbic acid (1 mM) did not block the Cd 2ϩ -induced rise in COX-2 levels (Fig. 8A, right panel) . More importantly, the decrease in GSH and the increase in PGE2 levels caused by the heavy metal were potentiated by ascorbic acid by a factor of 5-fold and 10 -38-fold, respectively (Fig. 8, B and D) .
DISCUSSION
The aim of this study was to identify mechanisms activated by disruption of the intracellular oxidation-reduction homeostasis and accumulation of ubiquitinated proteins, which could contribute to neuronal cell death. For this purpose, we treated mouse HT4 neuronal cells with cadmium because the heavy metal is an oxidative stressor that depletes GSH, increases the levels of protein-mixed disulfides, and leads to the accumulation of ubiquitinated proteins and neuronal cell death (19) .
The present investigations reveal that Cd 2ϩ specifically enhances COX-2 gene expression, at the mRNA and protein levels, without affecting COX-1 expression in the HT4 neuronal cells. In addition, the heavy metal induces a rise in the production of PGE2, a proinflammatory prostaglandin that is a product of COX-2. This result demonstrates that the de novo synthesized COX-2, resulting from Cd 2ϩ induction, is enzymatically active. Moreover, the increases in COX-2 expression were detected as early as a 10-h treatment with 15 M Cd 2ϩ , suggesting that the induction of a proinflammatory response is an early event in the cellular reaction to the heavy metal.
Whether the accumulation of ubiquitinated proteins and/or COX-2 up-regulation is a cause or a consequence of Cd 2ϩ cytotoxicity in our system remains unclear. Nevertheless, the cellular events brought about by the heavy metal in HT4 neuronal cells (19 and herein) mimic those we reported for proteasome inhibitors (22) . Like oxidative stress induced by cadmium, proteasome inhibition leads to the accumulation of ubiquitinated proteins, to the induction of a proinflammatory response, and to a loss in cell viability. Therefore, the data presented herein together with our previous findings from studies with cadmium or proteasome inhibitors (19, 22) suggest that disruption of the ubiquitin/proteasome pathway cooperates with COX-2 function in a neurodegenerative pathway. The fact that COX-2 plays a role in neurodegeneration is supported by several studies. For example, up-regulation of COX-2 precedes the appearance of neurofibrillary tangle-containing neurons and neurodegeneration in patients with Fukuyama-type congenital muscular dystrophy, a neurodegenerative disorder transmitted through autosomal recessive inheritance (28) . Similarly, both neurofibrillary tangle-containing and damaged neurons in Down's syndrome and AD were found to exhibit high expression of COX-2 (29) . ROS produced by COX-2 could be responsible for its role in the neurodegenerative process. It is well established that ROS are by-products of prostaglandin biosynthesis by cyclooxygenases, and these ROS are regarded as important contributors to tissue damage resulting from, for example, brain injury and ischemia (28, 30) .
Interestingly, ROS are currently being considered to act not only as toxic metabolites but also as signaling molecules that may regulate cellular processes such as apoptosis (31, 32) . ROS derived from Cd 2ϩ treatment may cause lipid peroxidation (33) . One of the products of lipid peroxidation, HNE, is a highly reactive aldehyde recognized as one of the most important mediators of the cytopathological effects of oxidative stress (34) . Our observation that Cd 2ϩ caused formation of HNEprotein adducts indicates that HNE may, in fact, be one of the molecules triggering some of the intracellular responses to Cd 2ϩ . In support of this hypothesis, a study involving a screen of 15 different oxidized fatty acid metabolite products of lipid peroxidation revealed that HNE was the only specific inducer of COX-2 in rat liver epithelial RL34 cells (35) . Moreover, HNE-modified proteins were shown to become ubiquitinated (36) and act as noncompetitive inhibitors of the proteasome (37) . Other studies demonstrated that HNE can directly modify the proteasome and inhibit its trypsin-like and caspase-like activities (36) . Consequently, under the conditions tested in our studies, HNE may be one of the molecules contributing to COX-2 up-regulation as well as to the accumulation of ubiquitinated proteins.
To confirm that ROS production mediates some of the Cd 2ϩ effects we treated HT4 cells with two antioxidants, namely NAC and ascorbic acid. NAC is a thiol-reducing agent known to increase GSH pools and to react with ROS in cells (38, 39) . The present studies demonstrate that NAC attenuates the Cd 2ϩ effects on cytotoxicity, formation of HNE-protein adducts, COX-2 induction, and PGE2 production, as well as the decline in GSH, confirming that oxidative stress is an important mechanism mediating cadmium toxicity. The demonstration that NAC decreases the HT4 neuronal cell loss in viability induced by 45 M Cd 2ϩ underscores the capability of the thiol-reducing agent to protect cells from oxidative stress. Because of their antioxidant properties, thiol-reducing agents such as NAC are emerging as potential therapeutic drugs to manage neurodegenerative disorders such as Parkinson's disease (38, 39) .
Ascorbic acid is an antioxidant and free radical scavenger effective against peroxyl and hydroxyl radicals, superoxide, singlet oxygen, and peroxynitrite (for review, see Ref. 40) . In our studies, however, ascorbic acid failed to prevent Cd 2ϩ cytotoxicity. It acted instead as a pro-oxidant in the presence of the heavy metal, potentiating its decrease in GSH. This free radical scavenger also increased the levels of cytotoxicity and PGE2 production induced by Cd 2ϩ . A recent report demonstrated that ascorbic acid in the presence of transition metals stimulates the decomposition of products of lipid peroxidation to fatty acid metabolites such as HNE (41) . Cd 2ϩ is a transition metal, and a synergism between ascorbic acid and the heavy metal may therefore be responsible for enhancing its cytotoxicity.
We also investigated whether COX-2 inhibition would prevent the loss of cell viability induced by Cd 2ϩ . Our studies revealed that celecoxib, a COX-2-specific inhibitor, increased the survival rate of HT4 cells treated with 15, 30, and 45 M Cd 2ϩ for 7 h and 15 M Cd 2ϩ for 24 h. This effect may be the result of celecoxib blocking a COX-mediated toxic pathway that is independent of eicosanoid biosynthesis. In this pathway lipid hydroperoxides, which are the precursors of fatty acid metabolites such as HNE, are produced enzymatically by cyclooxygenases (41) . COX-2 was found to be more efficient in producing this enzymatic reaction than COX-1 (41). Our studies demonstrate that celecoxib, however, failed to promote cell survival of HT4 cells treated for 24 h with 30 and 45 M Cd 2ϩ significantly. The celecoxib effect on Cd 2ϩ cytotoxicity, therefore, becomes concentration-dependent after longer treatments with the heavy metal. These results suggest that COX-2 activation plays an important role in the early phase of the cytotoxic process initiated by Cd 2ϩ . COX-2 inhibition, therefore, could be an important target for therapeutic intervention in the initial stages of neurodegeneration associated with oxidative stress. Accordingly, other studies demonstrated that treatment of AD patients with nonsteroidal anti-inflammatory drugs, which inhibit cyclooxygenases, slows the progression of the disease proportionally to the duration of the treatment (42) .
Our studies indicate that Cd 2ϩ may prevent COX-2 turnover because treatment with the heavy metal promotes the accumulation of ubiquitin-COX-2 conjugates. These findings are consistent with our previous demonstration that ubiquitin-COX-2 conjugates appear in HT4 cells treated with proteasome inhibitors (22) , suggesting that COX-2 may be turned over by the ubiquitin/proteasome pathway. In addition, Cd 2ϩ most likely perturbs COX-2 glycosylation. Accordingly, an unglycosylated 65-kDa form of COX-2 was detected consistently in Cd 2ϩ -treated but not in control cells. The heavy metal also increases the protein levels of the 72-and 74-kDa COX-2 forms, which are N-glycosylated at three and four sites, respectively (27) . N-Glycosylation of cyclooxygensases at three sites is required for them to achieve a native conformation and for activity, but the role of N-glycosylation at the fourth site remains unknown (27) .
In summary, these studies demonstrate that disruption of the intracellular sulfhydryl homeostasis and formation of HNE-protein adducts mediate Cd 2ϩ cytotoxicity. The heavy metal induces the accumulation of ubiquitinated proteins, cell death (19) , and a proinflammatory response manifested by up-regulation of COX-2 (shown in this report). It is possible that neurodegenerative factors, such as genetic make-up, age, or environmental toxins that mimic the cadmium effects, contribute to the development of initial cellular lesions containing ubiquitinated proteins. These neuronal inclusions, which are hallmarks of neurodegeneration, may, themselves, lead to neuronal cell death. The neurodegenerative process, however, could be exacerbated by stimulation of a proinflammatory response that would contribute to a more rapid decline in neuronal survival. Inhibition of COX-2 activation in the initial phases of the neurodegenerative process may therefore be an important target for preventive therapy.
